CBDNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Fast-tracks Development for CBD Pet Product Line
Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has accelerated development of several cannabidiol ("CBD") products for the domestic pet food market. Pivot's pet product line will be marketed under the brand "Pivot Naturals For Pets" and will include capsules and sachets that deliver bio-available CBD to pets produced using the company’s patented Ready-To-Infuse-Cannabis powder as well as a line of pet creams developed using its Thrudermic Transdermal Nanotechnology. Pivot Naturals For Pets products will target indications such as joint pain, inflammation, post-surgical pain and skin disorders. "Pivot's technologies are versatile…






